Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1/2 Study of RSV/hMPV Combination and hMPV Vaccines in Adults
NCT07628049Phase 2Recruiting
- Sponsor
- GSK
- Start
- Jun 2026
- Primary completion
- Apr 2029
- Countries
- 2
01
Overview
A Phase 2 trial of IVX-A12 in respiratory syncytial virus infection (RSV), human metapneumovirus infection (HMPV), sponsored by GSK. Started Jun 2026; status: recruiting.
02
Drugs
IVX-A12
03
Conditions
respiratory syncytial virus infection (RSV)human metapneumovirus infection (HMPV)
Beyond the preview
Go deeper on NCT07628049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07628049.